CIK 0001503802
- Non-accelerated filer
- Smaller reporting company
Karyopharm Therapeutics Inc.
Sign in to watch- Tickers
- KPTI KPTIQ
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 263931704
- Phone
- +1 617-658-0600
- Business address
- 85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459
Securities
- KPTI Common stock Nasdaq
- KPTIQ Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,135
- in 3 filings
Net −$2,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-07-09 | Kauffman Michael Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) | −7,500 | 377,803 | ||
| 2020-07-09 | Shacham Sharon President & CSO | Exercise or conversion | +7,500 | $4.75 | $36K | 763,989 |
| 2020-07-09 | Shacham Sharon President & CSO | Sale | −7,500 | $19.53 | $146K | 756,489 |
| 2020-07-09 | Shacham Sharon President & CSO | Exercise or conversion · Stock Option (right to buy) | −7,500 | 377,803 | ||
| 2020-06-22 | Kauffman Michael Chief Executive Officer | Exercise or conversion | +7,500 | $0.03 | $248 | 763,989 |
| 2020-06-22 | Kauffman Michael Chief Executive Officer | Sale | −7,500 | $20.00 | $150K | 756,489 |
| 2020-06-22 | Kauffman Michael Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) | −7,500 | 8,924 | ||
| 2020-06-22 | Shacham Sharon President & CSO | Exercise or conversion | +7,500 | $0.03 | $248 | 763,989 |
| 2020-06-22 | Shacham Sharon President & CSO | Sale | −7,500 | $20.00 | $150K | 756,489 |
| 2020-06-22 | Shacham Sharon President & CSO | Exercise or conversion · Stock Option (right to buy) | −7,500 | 8,924 | ||
| 2020-06-15 | Kauffman Michael Chief Executive Officer | Exercise or conversion | +7,143 | $0.03 | $236 | 763,632 |
| 2020-06-15 | Kauffman Michael Chief Executive Officer | Sale | −7,143 | $16.38 | $117K | 756,489 |
| 2020-06-15 | Kauffman Michael Chief Executive Officer | Exercise or conversion | +357 | $0.03 | $12 | 756,846 |
| 2020-06-15 | Kauffman Michael Chief Executive Officer | Sale | −357 | $16.20 | $6K | 756,489 |
| 2020-06-15 | Kauffman Michael Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) | −7,143 | 16,424 | ||
| 2020-06-15 | Kauffman Michael Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) | −357 | 0 | ||
| 2020-06-15 | Shacham Sharon President & CSO | Exercise or conversion | +7,143 | $0.03 | $236 | 763,632 |
| 2020-06-15 | Shacham Sharon President & CSO | Sale | −7,143 | $16.38 | $117K | 756,489 |
| 2020-06-15 | Shacham Sharon President & CSO | Exercise or conversion | +357 | $0.03 | $12 | 756,846 |
| 2020-06-15 | Shacham Sharon President & CSO | Sale | −357 | $16.20 | $6K | 756,489 |
Page 23 of 29 · 570 trades